A-share brain–computer interface sector spiked in the afternoon session. Baiyang Pharmaceutical and Meihao Medical rose over 10%. Aoyang Health had earlier logged three consecutive daily limit-ups. Boji Pharmaceutical, Aipeng Medical, Chuangxin Medical and Xiangyu Medical also rallied.

Chinese Defense Ministry spokesperson Senior Colonel Zhang Xiaogang said the Philippines, as this session's ASEAN DMM chair, allowed certain politicians to misuse public office and erected obstacles that prevented China from attending, actions that seriously undermine ASEAN consensus decision-making and the meeting's open, inclusive spirit.

Refinitiv reported that after Thursday’s US close Amazon and Intel results intensified concern about the cost of the AI build-out. Amazon fell about 7% after-hours and Intel dropped about 18%. Selling spread to AI cloud providers, with CoreWeave, Nebius and Iren each off roughly 6–7% after-hours. Heavy data‑centre capex is turning formerly low‑debt firms into major borrowers: Alphabet and Meta recorded net cash outflows in the September quarter, while Microsoft—so far the only large tech not burning cash—launched a $25bn bond offering on Thursday. Large techs may sustain these outlays, but investors are increasingly cautious toward smaller AI cloud companies that have taken on substantial debt to meet backlog.